Loading asset research
OS Therapies Incorporated Common Stock
OSTXNYSE · USD · StocksQuote as of · Exchange session not verified$1.66
+0.91%
Today
OSTX
Loading 1D prices…
Market cap
$77.7M
Volume
344.8K
52w high
$2.2552w low
$1.15Company profile
OS Therapies Incorporated Common Stock
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
NYSE
Display currency
USD
Location
ROCKVILLE, MD, United States
Employees
4
Fiscal year end
1231
CIK
1795091
Session & valuation
Open$1.66
Previous close$1.65
Day high$1.67
Day low$1.62
30-day avg. volume645.8K
Outstanding shares46.1M
Diluted EPS-$0.98
Latest annual period
P/E (trailing)-1.70
P/E (forward)4.79
Price / book-6.31
Beta-0.68
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| FBIOFortress Biotech Inc. Common Stock | $76.5M | $63.3M | +58.49% | -$0.07 | -2.56% | Buy |
| INCRIntercure Ltd. Ordinary Shares | $76.5M | — | — | -$1.36 | -3.84% | Unrated |
| GANXGain Therapeutics Inc. Common Stock | $79M | $0.00 | — | -$0.61 | -1.63% | Buy |
| LFVNLifevantage Corporation Common Stock (Delaware) | $79.3M | $182.6M | +2.78% | $0.40 | +1.45% | Hold |
| VRCAVerrica Pharmaceuticals Inc. Common Stock | $75.8M | $35.6M | -50.31% | -$1.68 | -5.63% | Buy |